AlveoliX AG news

Despite the covid-19 crisis and no mega-rounds of investment in 2020, Biotech start-ups are back at the top! Swiss Biotech startups collected more than CHF 800 million in 2020, an increase of 31% compared to 2019. This is linked to the fact that innovation in drug development is taking place in the long term and, to the constant growing worldwide trend of investments in Biotech.

A journey inside the complex human lung – AlveoliX’s goal is to

We are thrilled to be part of the new BRIDGE Discovery project granted by the SNSF Swiss National Science Foundation and Innosuisse to the Laboratory of Microbiology at the Université de Neuchâtel (LAMUN) in cooperation with the CHUV / Centre hospitalier universitaire vaudois, the SIB Swiss Institute of Bioinformatics, and SiMPLInext SA. 

The project led by Prof. 

The Swiss National Science Foundation SNSF and the Swiss Innovation Agency Innosuisse have granted a BRIDGE Discovery project to the Laboratory of Microbiology at the University of Neuchâtel (LAMUN) in cooperation with the Centre Hospitalier Universitaire Vaudois (CHUV), the Swiss Institute of Bioinformatics (SIB), and two innovative Swiss startups AlveoliX AG and SiMPLInext SA. The aim of this project is to demonstrate for the first time the applicability of ecological theory (initiall

We are very excited to welcome Léa Todeschini as Business Developer in our team! Léa will be responsible for the growth and development of new business while maintaining customer relationships. We are looking forward to grow and further develop our company together with Léa.

If you happen to be near our office, stop by and ask for an introduction. We know that Léa would like to meet you and learn more about your projects.